Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

siRNA-chitosan complexes in poly(lactic-co-glycolic acid) nanoparticles for the silencing of aquaporin-1 in cancer cells.

Stigliano C, Aryal S, de Tullio MD, Nicchia GP, Pascazio G, Svelto M, Decuzzi P.

Mol Pharm. 2013 Aug 5;10(8):3186-94. doi: 10.1021/mp400224u. Epub 2013 Jun 21.

PMID:
23789777
2.

Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.

Lee C, Choi JS, Kim I, Oh KT, Lee ES, Park ES, Lee KC, Youn YS.

Int J Nanomedicine. 2013;8:2975-83. doi: 10.2147/IJN.S48197. Epub 2013 Aug 9.

3.

Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.

Lee JY, Lee SH, Oh MH, Kim JS, Park TG, Nam YS.

J Control Release. 2012 Sep 10;162(2):407-13. doi: 10.1016/j.jconrel.2012.07.006. Epub 2012 Jul 16.

PMID:
22800573
4.

Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.

Zeng P, Xu Y, Zeng C, Ren H, Peng M.

Int J Pharm. 2011 Aug 30;415(1-2):259-66. doi: 10.1016/j.ijpharm.2011.05.053. Epub 2011 May 27.

PMID:
21645597
5.

PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.

Su WP, Cheng FY, Shieh DB, Yeh CS, Su WC.

Int J Nanomedicine. 2012;7:4269-83. doi: 10.2147/IJN.S33666. Epub 2012 Aug 3.

6.

Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery.

Chen M, Gao S, Dong M, Song J, Yang C, Howard KA, Kjems J, Besenbacher F.

ACS Nano. 2012 Jun 26;6(6):4835-44. doi: 10.1021/nn300106t. Epub 2012 May 31.

PMID:
22621383
7.

Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.

Jeon SY, Park JS, Yang HN, Woo DG, Park KH.

Biomaterials. 2012 Jun;33(17):4413-23. doi: 10.1016/j.biomaterials.2012.02.051. Epub 2012 Mar 15.

PMID:
22425025
8.

Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).

Wang G, Chen Y, Wang P, Wang Y, Hong H, Li Y, Qian J, Yuan Y, Yu B, Liu C.

Acta Biomater. 2016 Jan;29:248-260. doi: 10.1016/j.actbio.2015.10.017. Epub 2015 Oct 22.

PMID:
26476340
9.

Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.

Tahara K, Yamamoto H, Hirashima N, Kawashima Y.

Eur J Pharm Biopharm. 2010 Mar;74(3):421-6. doi: 10.1016/j.ejpb.2009.12.007. Epub 2009 Dec 23.

PMID:
20034563
10.

Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.

Cun D, Foged C, Yang M, Frøkjaer S, Nielsen HM.

Int J Pharm. 2010 May 5;390(1):70-5. doi: 10.1016/j.ijpharm.2009.10.023. Epub 2009 Oct 15.

PMID:
19836438
11.

Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.

Jagani HV, Josyula VR, Palanimuthu VR, Hariharapura RC, Gang SS.

Eur J Pharm Sci. 2013 Mar 12;48(4-5):611-8. doi: 10.1016/j.ejps.2012.12.017. Epub 2013 Jan 3.

PMID:
23291045
12.

The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.

Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z.

Pharm Res. 2010 Jul;27(7):1285-95. doi: 10.1007/s11095-010-0103-0. Epub 2010 Mar 23.

PMID:
20309616
13.
14.

Intracellular delivery of cysteine protease inhibitor cystatin by polymeric nanoparticles.

Cegnar M, Kos J, Kristl J.

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3087-94.

PMID:
17048522
15.

Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.

Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q.

Nanotechnology. 2013 Jun 21;24(24):245101. doi: 10.1088/0957-4484/24/24/245101. Epub 2013 May 23.

PMID:
23702815
16.

Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.

Lee C, Seo J, Hwang HS, Thao le Q, Lee S, Lee ES, Lee EH, Choi HG, Youn YS.

Biomed Pharmacother. 2016 Mar;78:226-33. doi: 10.1016/j.biopha.2016.01.027. Epub 2016 Feb 2.

PMID:
26898446
17.

[Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles].

Pan Y, Li YJ, Gao P, Ding PT, Xu H, Zheng JM.

Yao Xue Xue Bao. 2003 Jun;38(6):467-70. Chinese.

PMID:
14513811
18.

STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.

Alshamsan A, Haddadi A, Hamdy S, Samuel J, El-Kadi AO, Uludağ H, Lavasanifar A.

Mol Pharm. 2010 Oct 4;7(5):1643-54. doi: 10.1021/mp100067u. Epub 2010 Sep 14.

PMID:
20804176
19.

Preparation and hydrolytic erosion of differently structured PLGA nanoparticles with chitosan modification.

Ma FK, Li J, Kong M, Liu Y, An Y, Chen XG.

Int J Biol Macromol. 2013 Mar;54:174-9. doi: 10.1016/j.ijbiomac.2012.12.019. Epub 2012 Dec 19.

PMID:
23262384
20.

Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures.

Chronopoulou L, Massimi M, Giardi MF, Cametti C, Devirgiliis LC, Dentini M, Palocci C.

Colloids Surf B Biointerfaces. 2013 Mar 1;103:310-7. doi: 10.1016/j.colsurfb.2012.10.063. Epub 2012 Nov 20.

PMID:
23261553

Supplemental Content

Support Center